The Pharmaceutical Society of Australia (PSA) welcomes the Albanese Government’s 2025-26 Budget, investing in a number of measures that allow pharmacists to deliver timely, accessible care to Australians.
Of the key measures announced pre-Budget, PSA again reaffirms its support for the government’s record $573 million investment in women’s health initiatives, including funding for a nation-wide trial to boost access to treatment for uncomplicated urinary tract infections (UTIs) and hormonal contraception through community pharmacists, as well as the historic investment to lower the PBS general patient co-payment from $31.60 to $25.00 on 1 January 2026.
In particular, PSA welcomes the federal government’s investment in the further development of the Code of Ethics for Pharmacists, reflecting evolving practice and supporting pharmacists as new ethical paradigms arise.
PSA National President Associate Professor Fei Sim FPS said the work will ensure pharmacists are supported to practise to their full scope:
“Supporting pharmacists in ethical decision-making is particularly critical considering the rapid growth in scope of practice and evolving community expectations.
“PSA’s focus is on ensuring that pharmacists are able practise to their full scope, underpinned by the necessary support for professional practice, education and training.”
A/Prof Sim also reflected on the importance of the funding measures which will increase accessibility of care.
“PSA welcomes the federal government’s investment in women’s health, funding 250,000 Australian women with concession cards to access treatment for UTIs and oral contraception from their local pharmacist without an out-of-pocket consultation.
“We look forward to working with government, consumers and other stakeholders to implement this measure as soon as possible, ensuring that all women can access care when and where they need it.
“PSA also acknowledges the historic investment in the PBS, ensuring the cost burden of medicines is eased and more Australians can afford their medicines.
